You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Proliferation

Showing 1 - 25 of 4,968
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Subjects Trial in El Segundo (N-803)

Not yet recruiting
  • Healthy Subjects
  • El Segundo, California
    Chan Soon-Shiong Institute for Medicine
Sep 14, 2023

Prostate Cancer Trial in Gothenburg (Phytoestrogen-rich foods)

Recruiting
  • Prostate Cancer
  • Phytoestrogen-rich foods
  • Gothenburg, Västra Götalands Län, Sweden
    Sahlgrenska University Hospital
Jan 18, 2023

Study of Factors Regulating Mast Cell Proliferation

Recruiting
  • Mastocytosis
  • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Breast Cancer Trial in Shantou (dose-dense nab-paclitaxel followed by EC)

    Recruiting
    • Breast Cancer
    • dose-dense nab-paclitaxel followed by EC
    • Shantou, Guangdong, China
      Shantou Central Hospital
    Feb 4, 2023

    Oropharyngeal Cancer Trial in Tampa (Radiotherapy fractionation)

    Active, not recruiting
    • Oropharyngeal Cancer
    • Radiotherapy fractionation
    • Tampa, Florida
      H Lee Moffitt Cancer Center and Research Institute
    Feb 2, 2023

    Wet Macular Degeneration Trial in Prague (Aflibercept 40 MG/ML [Eylea], Brolucizumab-Dbll 120 MG/ML [Beovu], Ranibizumab 6 MG/ML

    Withdrawn
    • Wet Macular Degeneration
    • Aflibercept 40 MG/ML [Eylea]
    • +2 more
    • Prague, Czechia
      Department of Ophthalmology, Faculty hospital Kralovske Vinohrad
    Aug 7, 2022

    Lymphoproliferative Disorders, Autoimmune Lymphoproliferative, Primary T-cell Immunodeficiency Disorders Trial in Bethesda,

    Recruiting
    • Lymphoproliferative Disorders
    • +4 more
    • Immunosuppression Only Conditioning
    • +3 more
    • Bethesda, Maryland
    • +1 more
    Jan 25, 2023

    pH, Saliva, Dental Plaque Trial in Mexico City (Natural Water)

    Completed
    • pH
    • +2 more
    • Natural Water
    • Mexico City, Mexico
      Children´s Hospital of Mexico Federico Gómez
    Jun 23, 2022

    Prostate Cancer Trial in Quebec (EPA, Placebo)

    Active, not recruiting
    • Prostate Cancer
    • EPA
    • Placebo
    • Quebec, Canada
      Centre de Recherche Clinique et Evaluative en Oncologie - Hotel
    May 24, 2022

    Breast Cancer Trial in Kansas City, Westwood (Duavee)

    Completed
    Has Results
    • Breast Cancer
    • Kansas City, Kansas
    • +1 more
    Mar 8, 2022

    Ambiguous Melanocytic Proliferation

    Not yet recruiting
    • Melanoma
    • Immunomarkers
    • Strasbourg, France
      Les Hôpitaux Universitaires de Strasbourg
    Oct 11, 2021

    Breast Cancer Trial in Boston (Exercise Intervention)

    Active, not recruiting
    • Breast Cancer
    • Exercise Intervention
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Jan 5, 2022

    Head Neck Cancer Trial in New York (PET/CT Imaging)

    Withdrawn
    • Head and Neck Cancer
    • PET/CT Imaging
    • New York, New York
      Citigroup Biomedical Imaging Center
    Dec 21, 2021

    Kidney Transplantation, Kidney Transplant Rejection Trial in Guangzhou

    Not yet recruiting
    • Kidney Transplantation
    • Kidney Transplant Rejection
      • Guangzhou, Guangdong, China
        The First Affiliated Hospital, Sun Yat-sen University
      Mar 19, 2023

      Melanoma, NSCLC, Squamous Cell Carcinoma of Head and Neck Trial in United States (GEN-011, IL-2, Fludarabine)

      Terminated
      • Melanoma
      • +8 more
      • GEN-011
      • +3 more
      • Gilbert, Arizona
      • +7 more
      Jul 13, 2022

      Immunotoxicity, Anesthesia, Inert Gas Narcosis Trial in Mannheim (High dose propofol, fentanyl and sevoflurane, Low dose

      Completed
      • Immunotoxicity
      • +2 more
      • High dose propofol, fentanyl and sevoflurane
      • Low dose propofol, fentanyl and sevoflurane
      • Mannheim, Germany
        University Medicine of Mannheim, Dept. Anesthesiology and Critic
      May 17, 2022

      Breast Cancer Trial (tibolone, )

      Completed
      • Breast Cancer
      • (no location specified)
      Feb 2, 2022

      Candidate Molecules in Laryngeal Carcinoma

      Completed
      • Larynx Cancer
      • Larynx Carcinoma
      • Obtaining blood samples
      • Ankara, Turkey
        Hacettepe University Cancer Institute Dept. of Basic Oncology
      Jan 19, 2022

      Cancer, Tumor, Solid Trial in London ([18F]Fluoropivalate ([18F]Fluoro-2,2-Dimethylpropionic Acid), PET/CT)

      Recruiting
      • Cancer
      • Tumor, Solid
      • [18F]Fluoropivalate ([18F]Fluoro-2,2-Dimethylpropionic Acid)
      • PET/CT
      • London, United Kingdom
      • +2 more
      Mar 2, 2022

      Ki67 Proliferation Index of Pancreatic Neuroendocrine Neoplasia

      Completed
      • Neuroendocrine Tumors
        • (no location specified)
        Feb 16, 2021

        Invasive Breast Carcinoma, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7 Trial in Detroit (Laboratory Biomarker

        Active, not recruiting
        • Invasive Breast Carcinoma
        • +6 more
        • Detroit, Michigan
          Wayne State University/Karmanos Cancer Institute
        Jun 17, 2022

        Sickle Cell Disease, Umbilical Cord Blood, Hematopoietic Cell Proliferation Trial in Palo Alto, San Francisco (ECT-001-CB

        Withdrawn
        • Sickle Cell Disease
        • +2 more
        • ECT-001-CB (UM171-Expanded Cord Blood Transplant)
        • Palo Alto, California
        • +1 more
        Jun 29, 2022

        Physical Exercise on Tumor Proliferation of Luminal B Breast

        Active, not recruiting
        • Breast Cancer
        • Luminal B
        • Exercise
        • Stretching
        • Madrid, Spain
          Hospital General Universitario Gregorio Marañón
        Feb 2, 2022

        Early-Stage Breast Carcinoma, Estrogen Receptor Positive Tumor Trial in Stockholm (Paclitaxel, Tamoxifen + Palbociclib,

        Active, not recruiting
        • Early-Stage Breast Carcinoma
        • Estrogen Receptor Positive Tumor
        • Stockholm, Sweden
        • +2 more
        Jul 30, 2021

        Increased Inflammation-resolving Activity by Omega-3

        Recruiting
        • Resolution of Inflammation
        • Reduction of Cell Proliferation
        • MAG-SPM treatment on isolated PBMC cells
        • Isolated PBMC cells without treatment.
        • Rimouski, Quebec, Canada
          SCF Pharma
        Dec 16, 2021